Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Arthos

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Nature|April 12, 2019
Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRETMaolin Lu, Xiaochu Ma, Luis R Castillo-Menendez, et al.
Science Translational Medicine|January 26, 2018
Integrin α<sub>4</sub>β<sub>7</sub> expression on peripheral blood CD4<sup>+</sup> T cells predicts HIV acquisition and disease progression outcomesAida Sivro, Alexandra Schuetz, Daniel Sheward, et al.
Plos Pathogens|August 29, 2018
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7Sakaorat Lertjuthaporn, Claudia Cicala, Donald Van Ryk, et al.
JCI Insight|January 31, 2020
HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functionsDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Plos Pathogens|August 1, 2017
Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infectionGustavo H Kijak, Eric Sanders-Buell, Agnes-Laurence Chenine, et al.
Plos Pathogens|September 15, 2017
Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infectionGustavo H Kijak, Eric Sanders-Buell, Agnes-Laurence Chenine, et al.
Nature|November 25, 2011
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9Jason S McLellan, Marie Pancera, Chris Carrico, et al.
Iscience|February 8, 2021
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidatesIsabela Silva de Castro, Giacomo Gorini, Rosemarie Mason, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Nature|April 12, 2019
Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRETMaolin Lu, Xiaochu Ma, Luis R Castillo-Menendez, et al.
Science Translational Medicine|January 26, 2018
Integrin α<sub>4</sub>β<sub>7</sub> expression on peripheral blood CD4<sup>+</sup> T cells predicts HIV acquisition and disease progression outcomesAida Sivro, Alexandra Schuetz, Daniel Sheward, et al.
Plos Pathogens|August 29, 2018
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7Sakaorat Lertjuthaporn, Claudia Cicala, Donald Van Ryk, et al.
JCI Insight|January 31, 2020
HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functionsDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Plos Pathogens|August 1, 2017
Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infectionGustavo H Kijak, Eric Sanders-Buell, Agnes-Laurence Chenine, et al.
Plos Pathogens|September 15, 2017
Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infectionGustavo H Kijak, Eric Sanders-Buell, Agnes-Laurence Chenine, et al.
Nature|November 25, 2011
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9Jason S McLellan, Marie Pancera, Chris Carrico, et al.
Iscience|February 8, 2021
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidatesIsabela Silva de Castro, Giacomo Gorini, Rosemarie Mason, et al.
Pageof 11